Not checked for notices yet.
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
Marc G. Achen, Michael Jeltsch, Eola Kukk and 5 more
Proceedings of the National Academy of Sciences of the United States of America · 1998
Cited by papers we hold 15
- Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives · 2025No notice
- Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 · 2022No notice
- VEGFR1 signaling in retinal angiogenesis and microinflammation · 2021No notice
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer · 2020No notice
- Inflammation and Lymphatic Function · 2019No notice
- Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes · 2019No notice
- Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels · 2018No notice
- The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment · 2016No notice
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitors · 2009No notice
- Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer · 2009No notice
- First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours · 2006No notice
- Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis · 2006No notice
- Targeting lymphangiogenesis to prevent tumour metastasis · 2006No notice
- The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer · 2001No notice
- Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis · 1999No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.